Healthcare Active Stocks: Pfizer Inc. (NYSE:PFE), Abbott Laboratories (NYSE:ABT), Zogenix Inc. (NASDAQ:ZGNX), Boston Scientific (NYSE:BSX)

Trading in Pfizer Inc. (NYSE:PFE) was halted last week because of pending news. While we see that all the time in smaller biotechs, MannKind will likely be halted next week during an FDA advisory committee meeting. Pfizer Inc. (NYSE:PFE) stock performance was 0.85% in last session and finished the day at $32.18. Traded volume was 62.72million shares in the last session and the average volume … Continue reading Healthcare Active Stocks: Pfizer Inc. (NYSE:PFE), Abbott Laboratories (NYSE:ABT), Zogenix Inc. (NASDAQ:ZGNX), Boston Scientific (NYSE:BSX)

Active Stocks Healthcare: Arena Pharmaceuticals (NASDAQ:ARNA), Pfizer Inc. (NYSE:PFE), Merck & Co. (NYSE:MRK), Teva Pharmaceutical Industries (NYSE:TEVA)

Arena Pharmaceuticals Inc (NASDAQ: ARNA ) and VIVUS (NASDAQ: VVUS ) in early 2012 as each company headed into their regulatory reviews with the U.S. Food and Drug Administration, or FDA, for their respective obesity medications. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock performance was -2.84% in last session and finished the day at $6.49. Traded volume was 6.83million shares in the last session and the average … Continue reading Active Stocks Healthcare: Arena Pharmaceuticals (NASDAQ:ARNA), Pfizer Inc. (NYSE:PFE), Merck & Co. (NYSE:MRK), Teva Pharmaceutical Industries (NYSE:TEVA)

A US federal court yesterday invalidated Pfizer Inc.’s (NYSE:PFE) key patent covering its anti-inflammatory pill Celebrex. The patent, which was set to lapse in December 2015, would have given Pfizer an 18-month extension from the expiry of the patent for the major ingredient in the drug, celecoxib. Pfizer Inc. (NYSE:PFE) stock performance was -2.69% in last session and finished the day at $31.12. Traded volume … Continue reading Biotech Active Stocks: Pfizer Inc. (NYSE:PFE), Geron Corporation (NASDAQ:GERN), Cell Therapeutics (NASDAQ:CTIC), Chelsea Therapeutics International (NASDAQ:CHTP)

Shares of Plug Power Inc (NASDAQ:PLUG) rose Thursday after the company narrowed a quarterly per-share loss and said it expected to break even this year and quadruple orders. Plug Power Inc (NASDAQ:PLUG) stock performance was 17.65% in last session and finished the day at $8.00. Traded volume was 130,939,920 million shares in the last session and the average volume of the stock remained 37.58 million … Continue reading Investor’s Alert: Plug Power Inc (NASDAQ:PLUG), SIRIUS XM Holding (NASDAQ:SIRI), General Electric Company (NYSE:GE), Pfizer Inc. (NYSE:PFE)

Geron Corporation (NASDAQ:GERN) got bad news about its key imetelstat drug, as the FDA issued a clinical hold on the treatment for multiple myeloma and essential thrombocythemia. Geron Corporation (NASDAQ:GERN) stock performance was -61.59% in last session and finished the day at $1.69. Traded volume was 46,444,384 million shares in the last session and the average volume of the stock remained 4.64 million shares. The … Continue reading Biotech Most Active Stocks: Geron Corporation (NASDAQ:GERN), Pfizer Inc. (NYSE:PFE), OXiGENE Inc (NASDAQ:OXGN), Gilead Sciences (NASDAQ:GILD)

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) reported financial results for the fourth quarter and full year ended December 31, 2013 and provided an update on corporate developments. Net loss for the fourth quarter ended December 31, 2013 was $74.2 million, or $0.40 per share, compared to a net loss of $60.5 million, or $0.36 per share, for the same period in 2012. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock … Continue reading Biotech Active Runners: Ariad Pharmaceuticals (NASDAQ:ARIA), Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Novavax (NASDAQ:NVAX)